Home LiteratureArticle Details
PMID: 14518697 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Comparison of thymic function-related markers to predict early CD4 T-cell repopulation in adult HIV-infected patients on HAART.

Antiviral therapy ·Vol. 8 ·No. 4 ·2003-08-00 ·Pages 289-94

Ruiz-Mateos E, de la Rosa R, Soriano N, Martinez-Moya M, Rubio A, Sánchez-Quijano A, Lissen E, Leal M

Abstract

The aim of this work was to compare thymic function-related markers for predicting early CD4 T-cell repopulation in adult HIV-infected patients under HAART. Forty-three consecutive antiretroviral-naive patients were prospectively analysed for clinical, biochemical, immunological and virological parameters at starting HAART, and followed for 4 weeks and every 12 weeks thereafter. At baseline, all patients underwent a thoracic computer tomography scan, in order to measure thymic volume, as well, T-cell phenotype (naive CD4 and CD8 T cells) and the number of TREC-bearing cells were obtained. CD4 cell repopulation was considered as an increase > or = 200 cells/mm3 above baseline count. Twenty-seven patients (62.8%) increased > or = 200 cells/mm3 above baseline levels during the follow-up. The median time to event was 182 days (84-537 days). On the univariate analysis, to be younger than 36 years, showing a CD4 cell count > or = 272 cells/mm3, a total naive T-cell count > or = 128 cells/mm3, a TREC-bearing cell count > or = 0.74 cells/mm3, and a thymic volume > or =3.07 cc at baseline were statistically associated to the event studied. However, when the multivariate analysis was performed, only thymic volume at baseline was independently associated (P=0.002) to CD4 cell recovery. This co-variable was identified as a positive predictor [hazard ratio, 1.22 (95% confidence interval: 1.16-1.28)]. In summary, data presented herewith show that thymic volume is the best thymic function-related marker for predicting early CD4 T-cell recovery in adult HIV-infected patients under HAART.

MeSH Terms
Adult Antiretroviral Therapy, Highly Active Biomarkers CD4 Lymphocyte Count CD4-Positive T-Lymphocytes/immunology Female HIV Infections/drug therapy,immunology HIV-1/immunology Humans Male Predictive Value of Tests Prospective Studies Receptors, Antigen, T-Cell T-Lymphocyte Subsets/immunology Thymus Gland/diagnostic imaging,immunology Tomography, X-Ray Computed
Chemicals
Biomarkers Receptors, Antigen, T-Cell
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Ruiz-Mateos Ezequiel
Department of Internal Medicine, Virgen del Rocio University Hospital, Seville, Spain.
de la Rosa Rafael
Soriano Natalia
Martinez-Moya Manuel
Rubio Amalia
Sánchez-Quijano Armando
Lissen Eduardo
Leal Manuel
Article Info
Journal
Antiviral therapy
Abbr.
Antivir Ther
ISSN
1359-6535
Published
2003-08-00
Pages
289-94
Language
English
Region
England
NLM ID
9815705
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com